Pharmaceutical Industry

Supply of Unproven Ebola Drug Now Exhausted, as People Continue to Die from Outbreak

Supply of Unproven Ebola Drug Now Exhausted, as People Continue to Die from Outbreak
A leading physician in Sierra Leone's fight against Ebola has died from the disease, an official said Wednesday, as it emerged that another top doctor last month was considered for an experimental treatment. There was very little of the experimental treatment available, which has stoked debate about ethics on who should get it even though it hasn't been tested in humans. There is no way of knowing if the drug, known as ZMapp, made a difference in the few people who have gotten the now-exhausted supply of the drug.
origin Author: 
Clarence Roy-Macaulay and Maria Cheng
origin Blog: 

Amid Rampant Fraud, Medicare Moves to Tighten Oversight of Prescribers

Amid Rampant Fraud, Medicare Moves to Tighten Oversight of Prescribers
Ten years after Medicare’s vaunted prescription drug program was signed into law, the Obama administration and Congress are re-evaluating whether it does enough to stop inappropriate prescribing and fraud by physicians. Until now, the program’s top priority has been getting drugs into the hands of its elderly and disabled enrollees, earning it high praise from consumers and politicians. Medicare is now putting in place changes that would give greater priority to targeting fraud and curbing waste.
origin Author: 
Charles Ornstein and Tracy Weber
origin Blog: